Company Update (NYSE:LLY): Up Close With Apple, Facebook, Twitter, LinkedIn, And Eli Lilly

[at Forbes] – This is a busy earnings week with Apple and the social-media trio of Facebook, Twitter and LinkedIn scheduled to report. What will these high-profile tech names say about the state of social media? Slice of Apple It’s been a rough patch for technology companies that have already reported quarterly earnings. Will AAPL be able to Read more on this. Eli Lilly and Company (LLY) , with a current value of $82.09B, started the session at $77.46. Looking at today’s trading action, the company’s one day range from $77.15 to $78.00 and has traded between $67.88 and $92.85 over the past 12 months. Lilly (LLY) shares are currently priced at 21.99x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s -6.63x earnings multiple for the same period. And for income investors, the company pays shareholders $2.04 per share annually in dividends, yielding 2.62%. In a review of the consensus earnings estimate this quarter, 19 sell-side analysts are looking at $0.85 per share, which would be $0.02 worse than the year-ago quarter and a $0.01 sequential increase. The full-year EPS estimate is $3.54, which would be a $0.11 better than last year. The quarterly earnings estimate is predicated on a consensus revenue forecast of $4.82 Billion. If reported, that would be a 3.88% increase over the year-ago quarter. Recently, Societe Generale Initiated LLY at Hold (Apr 6, 2016). Previously, BMO Capital Markets upgraded LLY from Market Perform to Outperform. When considering if the stock is under or overvalued, the average price target is $94.18, which is 21.59% above where the stock opened this morning. See more in (NYSE:LLY) Similar Articles: Market Update: Eli Lilly & Company (NYSE:LLY) – Lilly’s Taltz® (ixekizumab) Receives U.S. FDA Approval for the Treatment of Moderate-to-Severe Plaque Psoriasis Company Update: Eli Lilly & Company (NYSE:LLY) – Lilly to Present at Cowen Health Care Conference Stock Update: Eli Lilly & Company (NYSE:LLY) – Lilly To Present At Leerink Partners Global Healthcare Conference